Table:
begin	end	state
1	16	non-cytoplasmic
17	38	transmembrane
39	61	cytoplasmic
62	88	transmembrane
89	92	non-cytoplasmic
93	116	transmembrane
117	141	cytoplasmic
142	162	transmembrane
163	175	non-cytoplasmic
176	198	transmembrane
199	206	cytoplasmic
207	228	transmembrane
229	247	non-cytoplasmic
248	257	transmembrane
258	300	cytoplasmic
301	323	transmembrane
324	345	non-cytoplasmic
346	367	transmembrane
368	386	cytoplasmic
387	410	transmembrane
411	415	non-cytoplasmic
416	437	transmembrane
438	488	cytoplasmic

Input:
>7025996 FitnessBrowser__ANA3:7025996
MLETIVNFLNALLWGKLLVYGLVGAGLYFTLRLVFIQLTHFKHSLKVMTMSRQGCESGLS
SFQVFCTSMAARVGAGNMAGVAVAIGAAGPGAVFWMWLIAMLGMATAMVESTLAQVYKVR
DTNGQFRGGPSYYMEKGLGQRWMGVLFAFFLIIAFGLVFNAVQANTITGAMERVFGFNPT
YVGIGLVLASGFVIVGGLRKVARVSEFIVPIMALAYILIAFIIVLFNLDQLPAIISLIVK
SAFGWQEAAAGGVAYTVAQAMQAGIARGLFSNEAGMGSAANVAASASPNPNHPASQGFVQ
MMGVFVDTIVICTATAAIILLSGDIGSSEDGIRLTINAMSNHVGDWGGAFIAIAIFLFCF
TSIIANYSYAETNVMFLTGNSTKALPLFRLCVLGMVMFGAVAKISLVWNLADVSMGLMAT
VNIIALLLLSGLAIRVINDYCEQLKSGKMPEFDRSKFPELMEQLDDGIWQDNSANEQAKA
RTESALSR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server